Format

Send to

Choose Destination
J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 3:S252-5. doi: 10.1097/QAI.0000000000001089.

Ethical Issues to Consider in the Design of HIV Prevention Trials Involving Transgender People.

Author information

1
Center for the AIDS Programme of Research in South Africa (CAPRISA), Nelson R. Mandela School of Medicine, Durban, South Africa.

Abstract

Although transgender women have been included in HIV prevention pre-exposure prophylaxis studies, no pre-exposure prophylaxis study has focused exclusively on transgender persons. Drawing on the cardinal principles of ethics espoused in the Belmont Report, this work highlights, among other issues, that (1) the principle of Justice requires the HIV prevention field to focus exclusively on transgender persons, (2) the disclosure of potential study-related risks to study participants demonstrates Respect for Persons, and (3) devising risk mitigation plans, optimizing a proposed study's standard of care, and the provision of ancillary care satisfy the principle of Beneficence.

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center